Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Teduglutide in Parenteral Nutrition–Dependent Short Bowel Syndrome
2004-000438-35Phase 3Completed
- Sponsor
- NPS Pharmaceuticals
- Start
- Aug 2004
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of teduglutide in short bowel syndrome (SBS), sponsored by NPS Pharmaceuticals. Primary endpoints: Primary efficacy response rate and Safety and tolerability of teduglutide. Started Aug 2004; status: completed.
02
Drugs
teduglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on 2004-000438-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000438-35.